293 related articles for article (PubMed ID: 33801157)
1. SMADS-Mediate Molecular Mechanisms in Sjögren's Syndrome.
Sisto M; Ribatti D; Lisi S
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801157
[TBL] [Abstract][Full Text] [Related]
2. The TGF-
Sisto M; Lorusso L; Ingravallo G; Tamma R; Ribatti D; Lisi S
Mediators Inflamm; 2018; 2018():1965935. PubMed ID: 30598637
[TBL] [Abstract][Full Text] [Related]
3. TGF-β Pathway in Salivary Gland Fibrosis.
Zhang X; Yun JS; Han D; Yook JI; Kim HS; Cho ES
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266300
[TBL] [Abstract][Full Text] [Related]
4. IL-6 Contributes to the TGF-β1-Mediated Epithelial to Mesenchymal Transition in Human Salivary Gland Epithelial Cells.
Sisto M; Tamma R; Ribatti D; Lisi S
Arch Immunol Ther Exp (Warsz); 2020 Sep; 68(5):27. PubMed ID: 32914376
[TBL] [Abstract][Full Text] [Related]
5. Elevated
Liu Z; Li F; Pan A; Xue H; Jiang S; Zhu C; Jin M; Fang J; Zhu X; Brown MA; Wang X
Front Immunol; 2019; 10():795. PubMed ID: 31068931
[TBL] [Abstract][Full Text] [Related]
6. Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren's syndrome and non-autoimmune sicca.
Blokland SLM; Hillen MR; van Vliet-Moret FM; Bikker A; de Jager W; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
RMD Open; 2019; 5(1):e000772. PubMed ID: 30713719
[TBL] [Abstract][Full Text] [Related]
7. TGFβ1-Smad canonical and -Erk noncanonical pathways participate in interleukin-17-induced epithelial-mesenchymal transition in Sjögren's syndrome.
Sisto M; Lorusso L; Ingravallo G; Ribatti D; Lisi S
Lab Invest; 2020 Jun; 100(6):824-836. PubMed ID: 31925325
[TBL] [Abstract][Full Text] [Related]
8. Progenitor cell niche senescence reflects pathology of the parotid salivary gland in primary Sjögren's syndrome.
Wang X; Bootsma H; Terpstra J; Vissink A; van der Vegt B; Spijkervet FKL; Kroese FGM; Pringle S
Rheumatology (Oxford); 2020 Oct; 59(10):3003-3013. PubMed ID: 32159757
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling of epithelium-associated FcRL4
Verstappen GM; Ice JA; Bootsma H; Pringle S; Haacke EA; de Lange K; van der Vries GB; Hickey P; Vissink A; Spijkervet FKL; Lessard CJ; Kroese FGM
J Autoimmun; 2020 May; 109():102439. PubMed ID: 32201227
[TBL] [Abstract][Full Text] [Related]
10. The Multiple Roles of B Cells in the Pathogenesis of Sjögren's Syndrome.
Du W; Han M; Zhu X; Xiao F; Huang E; Che N; Tang X; Zou H; Jiang Q; Lu L
Front Immunol; 2021; 12():684999. PubMed ID: 34168653
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-17 and -22 synergy linking inflammation and EMT-dependent fibrosis in Sjögren's syndrome.
Sisto M; Lorusso L; Tamma R; Ingravallo G; Ribatti D; Lisi S
Clin Exp Immunol; 2019 Nov; 198(2):261-272. PubMed ID: 31165469
[TBL] [Abstract][Full Text] [Related]
12. Decreased circulating CXCR3 + CCR9+T helper cells are associated with elevated levels of their ligands CXCL10 and CCL25 in the salivary gland of patients with Sjögren's syndrome to facilitate their concerted migration.
Blokland SLM; Kislat A; Homey B; Smithson GM; Kruize AA; Radstake TRDJ; van Roon JAG
Scand J Immunol; 2020 Mar; 91(3):e12852. PubMed ID: 31733111
[TBL] [Abstract][Full Text] [Related]
13. Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway.
Lisi S; Sisto M; D'Amore M; Lofrumento DD
Int Immunol; 2015 Apr; 27(4):183-94. PubMed ID: 25381666
[TBL] [Abstract][Full Text] [Related]
14. Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren's syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology?
Blokland SLM; Hillen MR; Wichers CGK; Zimmermann M; Kruize AA; Radstake TRDJ; Broen JCA; van Roon JAG
RMD Open; 2019; 5(1):e000701. PubMed ID: 30713717
[No Abstract] [Full Text] [Related]
15. Signalling pathways identified in salivary glands from primary Sjögren's syndrome patients reveal enhanced adipose tissue development.
Aqrawi LA; Jensen JL; Øijordsbakken G; Ruus AK; Nygård S; Holden M; Jonsson R; Galtung HK; Skarstein K
Autoimmunity; 2018 May; 51(3):135-146. PubMed ID: 29504848
[TBL] [Abstract][Full Text] [Related]
16. IL-2 Inhibition of Th17 Generation Rather Than Induction of Treg Cells Is Impaired in Primary Sjögren's Syndrome Patients.
Luo J; Ming B; Zhang C; Deng X; Li P; Wei Z; Xia Y; Jiang K; Ye H; Ma W; Liu Z; Li H; Yang XP; Dong L
Front Immunol; 2018; 9():1755. PubMed ID: 30150979
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Ca(2+) Sensor STIM1 by Exosomal Transfer of Ebv-miR-BART13-3p is Associated with Sjögren's Syndrome.
Gallo A; Jang SI; Ong HL; Perez P; Tandon M; Ambudkar I; Illei G; Alevizos I
EBioMedicine; 2016 Aug; 10():216-26. PubMed ID: 27381477
[TBL] [Abstract][Full Text] [Related]
18. B7-H3 participates in human salivary gland epithelial cells apoptosis through NF-κB pathway in primary Sjögren's syndrome.
Li P; Yang Y; Jin Y; Zhao R; Dong C; Zheng W; Zhang T; Li J; Gu Z
J Transl Med; 2019 Aug; 17(1):268. PubMed ID: 31412888
[TBL] [Abstract][Full Text] [Related]
19. Two major Smad pathways in TGF-beta superfamily signalling.
Miyazawa K; Shinozaki M; Hara T; Furuya T; Miyazono K
Genes Cells; 2002 Dec; 7(12):1191-204. PubMed ID: 12485160
[TBL] [Abstract][Full Text] [Related]
20. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition.
Thuault S; Tan EJ; Peinado H; Cano A; Heldin CH; Moustakas A
J Biol Chem; 2008 Nov; 283(48):33437-46. PubMed ID: 18832382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
